You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 126 No. 5, November 1970 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (99)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Uremic Lipemia

An Unrecognized Abnormality in Triglyceride Production and Removal

John D. Bagdade, MD

Arch Intern Med. 1970;126(5):875-881.


Abstract

Basal plasma triglyceride (TG) concentrations were increased in 13 patients with non-nephrotic uremia who were not receiving dialysis therapy (164 ± 62 mg/100 ml, mean ± SD) and 25 uremic patients who were undergoing dialysis (276 ± 250 mg/100 ml). Basal immunoreactive insulin levels of both uremic groups were higher than nonuremic subjects of the same weight. In the group undergoing dialysis triglyceride and immunoreactive insulin (IRI) were directly related (r = 0.58, P < 0.02), which suggests that increased hepatic synthesis of triglyceride-rich lipoprotein may contribute to triglyceride elevation in uremia. In addition, peak postheparin lipolytic activity, an indirect estimate of tissue lipoprotein lipase and triglyceride removal capacity, was subnormal in all uremic subjects. Hypertriglyceridemia appears to be a previously unrecognized consequence of non nephrotic uremia. Alteration in both triglyceride production and assimilation may contribute to this abnormality.



Author Affiliations

Seattle

From the Division of Metabolism, Seattle Veterans Administration Hospital and the Department of Medicine, University of Washington School of Medicine, Seattle.


Footnotes

Received for publication July 8, 1970; accepted July 16.

Read before the session entitled "Intermediary Metabolic Disorders" (Edwin L. Bierman, MD, chairman) of the Symposium on Uremic Toxins sponsored by the National Institute of Arthritis and Metabolic Diseases, Monterey, Calif, March 19,1970.

Reprint requests to 4435 Beacon Ave South, Seattle 98108 (Dr. Bagdade).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Angiographic coronary diffuseness and outcomes in dialysis patients undergoing coronary artery bypass grafting surgery
Wong et al.
Eur. J. Cardiothorac. Surg. 2003;24:388-392.
ABSTRACT | FULL TEXT  

Coronary artery bypass grafting in patients who require long-term dialysis
Khaitan et al.
Ann. Thorac. Surg. 2000;69:1135-1139.
ABSTRACT | FULL TEXT  

Immediate and long-term results of coronary revascularization in patients undergoing chronic hemodialysis
Castelli et al.
Eur. J. Cardiothorac. Surg. 1999;15:51-54.
ABSTRACT | FULL TEXT  

Coronary Artery Bypass Surgery in Patients on Chronic Hemodialysis: A Case-Control Study
Deutsch et al.
ANN INTERN MED 1989;110:369-372.
ABSTRACT  

Successful Simultaneous Renal Transplantation and Abdominal Aortic Aneurysmectomy
Cerilli et al.
Arch Surg 1977;112:1218-1219.
ABSTRACT  

Defective Triglyceride Removal in Lipemia Associated with Peritoneal Dialysis and Haemodialysis
CATTRAN et al.
ANN INTERN MED 1976;85:29-33.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1970 American Medical Association. All Rights Reserved.